quetiapine (Q408535)

reactant

1 reference

Gene Ontology release 2019-11-16

has use

medication

0 references

chemical structure

Quetiapine.svg
512 × 372; 6 KB

0 references

mass

383.166748 dalton

1 reference

quetiapine (English)

3 October 2016

C₂₁H₂₅N₃O₂S

1 reference

quetiapine (English)

19 November 2016

C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42

1 reference

quetiapine (English)

19 November 2016

0.4 gram

route of administration

oral administration

1 reference

https://www.whocc.no/atc_ddd_index/?code=N05AH04

1 reference

14 February 2018

World Health Organisation international non-proprietary name

quetiapine (English)

1 reference

quetiapine (English)

medical condition treated

3 October 2016

1 reference

schizophreniform disorder

13 December 2016

1 reference

13 December 2016

1 reference

13 December 2016

1 reference

2 October 2018

personality disorder

1 reference

generalized anxiety disorder

2 October 2018

1 reference

2 October 2018

Alzheimer's disease

1 reference

2 October 2018

mental disorder

1 reference

2 October 2018

mood disorder

1 reference

2 October 2018

insomnia

1 reference

2 October 2018

psychosis

1 reference

2 October 2018

substance abuse

1 reference

post-traumatic stress disorder

2 October 2018

1 reference

obsessive-compulsive disorder

2 October 2018

1 reference

2 October 2018

anxiety

1 reference

borderline personality disorder

2 October 2018

1 reference

2 October 2018

schizoaffective disorder

1 reference

2 October 2018

anxiety disorder

1 reference

2 October 2018

sleep-wake disorder

1 reference

significant drug interaction

2 October 2018

1 reference

A reference set of clinically relevant adverse drug-drug interactions

paliperidone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

trimipramine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

amitriptyline

1 reference

A reference set of clinically relevant adverse drug-drug interactions

risperidone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(E/Z)-doxepin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

droperidol

1 reference

A reference set of clinically relevant adverse drug-drug interactions

pimozide

1 reference

A reference set of clinically relevant adverse drug-drug interactions

aripiprazole

1 reference

A reference set of clinically relevant adverse drug-drug interactions

haloperidol

1 reference

A reference set of clinically relevant adverse drug-drug interactions

sotalol

1 reference

A reference set of clinically relevant adverse drug-drug interactions

levomepromazine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

zuclopenthixol

1 reference

A reference set of clinically relevant adverse drug-drug interactions

periciazine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-sulpiride

1 reference

A reference set of clinically relevant adverse drug-drug interactions

imipramine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

olanzapine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

chlorpromazine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

clomipramine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

clozapine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

apomorphine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

paliperidone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

trimipramine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

amitriptyline

1 reference

A reference set of clinically relevant adverse drug-drug interactions

risperidone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(E/Z)-doxepin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

droperidol

1 reference

A reference set of clinically relevant adverse drug-drug interactions

pimozide

1 reference

A reference set of clinically relevant adverse drug-drug interactions

aripiprazole

1 reference

A reference set of clinically relevant adverse drug-drug interactions

haloperidol

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-methadone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(±)-promethazine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

sotalol

1 reference

A reference set of clinically relevant adverse drug-drug interactions

erythromycin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

levomepromazine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-sulpiride

1 reference

A reference set of clinically relevant adverse drug-drug interactions

crizotinib

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-hydroxyzine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

imipramine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

olanzapine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

chlorpromazine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

clomipramine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

apomorphine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

zuclopenthixol

1 reference

A reference set of clinically relevant adverse drug-drug interactions

clozapine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

pethidine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

pethidine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

periciazine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(R,R)-tramadol

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(R,R)-tramadol

1 reference

A reference set of clinically relevant adverse drug-drug interactions

morphine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

morphine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

oxycodone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

oxycodone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

hydromorphone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

hydromorphone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

dihydrocodeine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

dihydrocodeine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

codeine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

codeine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tapentadol

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tapentadol

1 reference

A reference set of clinically relevant adverse drug-drug interactions

itraconazole

1 reference

A reference set of clinically relevant adverse drug-drug interactions

voriconazole

1 reference

A reference set of clinically relevant adverse drug-drug interactions

clarithromycin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

Ketoconazole

1 reference

A reference set of clinically relevant adverse drug-drug interactions

buprenorphine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

buprenorphine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

fentanyl

1 reference

A reference set of clinically relevant adverse drug-drug interactions

posaconazole

1 reference

A reference set of clinically relevant adverse drug-drug interactions

ritonavir

1 reference

A reference set of clinically relevant adverse drug-drug interactions

alfentanil

1 reference

A reference set of clinically relevant adverse drug-drug interactions

alfentanil

1 reference

A reference set of clinically relevant adverse drug-drug interactions

alfentanil

1 reference

A reference set of clinically relevant adverse drug-drug interactions

sufentanil

1 reference

A reference set of clinically relevant adverse drug-drug interactions

sufentanil

1 reference

A reference set of clinically relevant adverse drug-drug interactions

cognitive disorder

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

sedation

1 reference

A reference set of clinically relevant adverse drug-drug interactions

syncope

1 reference

A reference set of clinically relevant adverse drug-drug interactions

fosphenytoin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

physically interacts with

5-hydroxytryptamine receptor 1A

1 reference

5-hydroxytryptamine receptor 1D

17 August 2016

1 reference

5-hydroxytryptamine receptor 1E

17 August 2016

1 reference

5-hydroxytryptamine receptor 1F

17 August 2016

1 reference

5-hydroxytryptamine receptor 2A

17 August 2016

1 reference

17 August 2016

1 reference

17 August 2016

Histamine receptor H1

1 reference

Solute carrier family 6 member 2

17 August 2016

1 reference

17 August 2016

legal status (medicine)

boxed warning

1 reference

https://nctr-crs.fda.gov/fdalabel/ui/spl-summaries/criteria/343802

Australian pregnancy category B3

FDA-sourced list of all drugs with black box warnings (Use Download Full Results and View Query links. (English)

pregnancy category

1 reference

imported from Wikimedia project

English Wikipedia

US pregnancy category C

1 reference

imported from Wikimedia project

English Wikipedia

LiverTox likelihood score

LiverTox toxicity likelihood category B

1 reference

8 April 2021

https://www.ncbi.nlm.nih.gov/books/n/livertox/Quetiapine

15 May 2018

1 reference

5 March 2018

1 reference

5 March 2018

1 reference

5 March 2018

1 reference

5 March 2018

QUEtiapine

Institute for Safe Medication Practices

1 reference

https://www.ismp.org/recommendations/tall-man-letters-list

Institute for Safe Medication Practices

2 September 2022

SEROquel

has characteristic

Tall Man lettering

issued by

1 reference

https://www.ismp.org/recommendations/tall-man-letters-list

2 September 2022

0 references

0 references

0 references

0 references

Quetiapine

0 references

Identifiers

InChI

InChI=1S/C21H25N3O2S/c25-14-16-26-15-13-23-9-11-24(12-10-23)21-17-5-1-3-7-19(17)27-20-8-4-2-6-18(20)22-21/h1-8,25H,9-16H2

1 reference

URKOMYMAXPYINW-UHFFFAOYSA-N

quetiapine (English)

19 November 2016

2 references

quetiapine (English)

19 November 2016

ChEBI release 2020-09-01

CAS Registry Number

111974-69-7

2 references

URKOMYMAXPYINW-UHFFFAOYSA-N

quetiapine (English)

19 November 2016

10 April 2021

https://commonchemistry.cas.org/detail?cas_rn=111974-69-7

1 reference

Quetiapine (English)

19 November 2016

1 reference

quetiapine (English)

19 November 2016

mapping relation type

1 reference

QUETIAPINE (English)

19 November 2016

1 reference

splash10-001i-0039000000-6e58caa07d6f7951f23e

QUETIAPINE (English)

19 November 2016

1 reference

0 references

HSDB ID

7557

1 reference

Hazardous Substances Data Bank

28 October 2019

QUETIAPINE (English)

10 May 2021

1 reference

Mapping file of InChIStrings, InChIKeys and DTXSIDs for the EPA CompTox Dashboard

DSSTOX compound identifier

0 references

0 references

0 references

601-143-7

1 reference

ECHA Substance Infocard database

ECHA Substance Infocard ID

100.131.193

27 December 2018

ECHA Substance Infocard ID

2-[2-(4-{2-thia-9-azatricyclo[9.4.0.0³,⁸]pentadeca-1(11),3(8),4,6,9,12,14-heptaen-10-yl}piperazin-1-yl)ethoxy]ethan-1-ol (English)

quotation

CAS no.: 111974-69-7 (English)

100.131.193

1 reference

ECHA Substance Infocard database

ECHA Substance Infocard ID

100.131.193

27 December 2018

2-[2-(4-{2-thia-9-azatricyclo[9.4.0.0³,⁸]pentadeca-1(11),3(8),4,6,9,12,14-heptaen-10-yl}piperazin-1-yl)ethoxy]ethan-1-ol (English)

quotation

CAS no.: 111974-69-7 (English)

1 reference

Quetiapine (English)

publication date

17 November 2015

1 reference

quetiapine (English)

19 November 2016

0 references

1 reference

quetiapine (English)

19 November 2016

1 reference

Quetiapine (English)

Human Metabolome Database ID

19 November 2016

HMDB0005021

1 reference

based on heuristic

inferred from InChIKey

1 reference

quetiapine (English)

MedlinePlus drug identifier

19 November 2016

a698019

0 references

PatientsLikeMe treatment ID

0 references

1 reference

quetiapine (English)

19 November 2016

0 references

1 reference

1 reference

quetiapine (English)

3 October 2016

1 reference

quetiapine (English)

APA Dictionary of Psychology entry

3 October 2016

quetiapine

0 references

BBC Things ID

5787e136-e5dc-406b-8b7a-1a0690e0d633

1 reference

1 reference

28 October 2013

0 references

Microsoft Academic ID

0 references

0 references

1 reference

26 January 2022

https://docs.openalex.org/download-snapshot/snapshot-data-format

1 reference

26 January 2022

https://docs.openalex.org/download-snapshot/snapshot-data-format

Römpp online ID

RD-17-00192

1 reference

imported from Wikimedia project

German Wikipedia

Store medisinske leksikon ID

kvetiapin

mapping relation type

exact match

subject named as

kvetiapin

1 reference

Store norske leksikon

UK Parliament thesaurus ID

5 June 2020

Store norske leksikon ID

Kvetiapin

0 references

447920

subject named as

Quetiapine

0 references

UMLS CUI

C0123091

1 reference